Improving clinical outcomes of MTBI and PTSD ; identification of Neuromarkers for assessment and neuromodulation for treatment

Home Editorial policy and Editors Contributors Upcoming Live Web Casts Practice of Psychotherapy The Internet in Practice Group Therapy Jungian Analysis The Conversational Model Self Psychology Brief Interpersonal Therapies Dialectical Behaviour Therapy Cognitive Behavioural Therapy Process Oriented Psychology Gestalt Therapy Psychoanalysis Attachment Family Therapy Couple Therapy Child and Adolescent EMDR Transpersonal Psychotherapy Advances in Neuroscience General Practice Phenomenology Appreciative Inquiry Dreams and Dreaming Art Therapy Mindfulness Yoga and Therapy Existential Therapy Refugee Trauma Cross-Cultural Approaches Indigenous Culture Testimonial Therapy Religion and Spirituality Kinesiology Acupuncture Nurses in Mental Health Forensic psychology Patient & Client Perspective Ethics Philosophy and the mind Editors Review Resources

Improving clinical outcomes of MTBI and PTSD ; identification of Neuromarkers for assessment and neuromodulation for treatment
Dr Roger deBeus

Access to Lectures | Speaker

Mild traumatic brain injury (MTBI) and posttraumatic stress disorder (PTSD) are complicated pervasive disorders that have both overlapping and different symptom profiles. Further, each patient presents with a unique set of symptoms which highlights the need for individualized treatment. In addition to established assessment and treatments, using neuropsychological (NP) and quantitative electroencephalogram (QEEG) profiling can help generate an individualized approach to assess and subsequently treat these disorders. This presentation will identify various NP and QEEG profiles specific to MTBI and PTSD, and then present how neuromodulation modalities such as neurofeedback and computerized training may help these populations improve functioning.

Recorded: 14th - 15th of August 2010
Annual conference of The Applied Neuroscience Society of Australia
Brain Health in the 21st Century (evidence Based & emerging neurotechnologies)

Roger deBeus

more about this speaker

other talks by the speaker

Click on a link above to share this page with your networking site.

Media

TITLE	SPEAKER	DURATION
Improving clinical outcomes of MTBI and PTSD ; identification of Neuromarkers for assessment and neuromodulation for treatment	Roger deBeus	32'16"
Improving clinical outcomes of MTBI and PTSD ; identification of Neuromarkers for assessment and neuromodulation for treatment	Roger deBeus
Improving clinical outcomes of MTBI and PTSD ; identification of Neuromarkers for assessment and neuromodulation for treatment	Roger deBeus

Dr Roger deBeus

Dr. Roger deBeus started his EEG career at New York Hospital/Cornell Medical Center in the Chronobiology Lab. He has been funded on several grants to conduct research on neurofeedback with AD/HD, substance abuse, and traumatized female adolescents. He is a Past-President of the International Society of Neurofeedback and Research, Consulting Editor for the Journal of Neurotherapy, QEEG and Neurofeeback Associate Editor for the Biofeedback journal. He currently holds a Clinical Assistant Professor position in the department of Psychiatry, Quillen College of Medicine, at East Tennessee State University. Dr. Roger deBeus is also a Site Principal Investigator for the International Study to Predict Optimised Treatment (iSPOT) for both depression and AD/HD

Drs. Roger and Mary deBeus both received a doctorate in Health Psychology/Behavioral Medicine from the University of North Texas. During graduate school they both were employed at one of the few neurotherapy clinics housed at a university. Drs. deBeus are Licensed Clinical Psychologists and BCIA-EEG Fellows, and have been practicing for over 20 years combined with inpatient and outpatient populations. They have used QEEG as part of an assessment battery to help guide neurofeedback protocols with several hundred patients during this time. These doctors have utilized a strong scientific background combined with clinical expertise to help many clinicians improve their clinical neurofeedback outcomes. They both provide QEEG consulting services that analyzes EEG/QEEG data, generates Functional QEEG reports, and provides neurofeedback recommendations.